IMMX News and Press, Immix Biopharma Inc. From 01/05/22

2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks like 2022 will be “THE” year for biotech sector. In a recent note from Piper Sandler analyst Christopher Raymond and ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to kick off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com Many of the biggest stocks on the move today are continu...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BlueCity Holdings (NASDAQ: BLCT ) has announced a buyout offer for the company’s stock from Baoli Ma and Spriver Tech Limited. Source: Shutterstock.com Let’s dive into that news below with all the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Immix Biopharma (NASDAQ: IMMX ) stock is taking off on Monday thanks to a Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration (FDA). Source: Bukhta Yurii / Shutterstock.com This...

Shares of Immix Biopharma Inc. (NASDAQ:IMMX) traded at a new 52-week high today of $8.52. This new high was reached on above average trading volume as 6.8 million shares traded hands, while the average 30-day volume is approximately 461,000 shares. Immix Biopharma Inc is a clinical-stage...

Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at the time of marketing approval of IMX-110. PRV holders can benefit from an expedited six-month review of a new drug ...